Genmab (Copenhagen:GMAB) Q3 2026 Earnings Call
Genmab (Copenhagen:GMAB) reports Q3 2026 results on this call. Live coverage runs here, and the full replay with transcript and chapters lands on this page after the call.
- Company
- Genmab A/S (OMXCOP:GMAB)
- Period
- Q3 2026 earnings call
- Date
- Thu, Nov 5, 2026, 12:00 PM ET
Latest news releases
- Copenhagen:GMAB — Genmab A/S Announces Rinatabart Sesutecan (Rina-S) Phase 2 RAINFOLTM-01 Results Demonstrated Durable and Clinically Meaningful Responses in Patients with Platinum-Resistant Ovarian Cancer · Sat, Oct 3, 2026
- Copenhagen:GMAB — Genmab Announces Rinatabart Sesutecan (Rina-S®) Phase 2 RAINFOL™-01 Results Demonstrated Durable and Clinically Meaningful Responses in Patients with Platinum-Resistant Ovarian Cancer · Sat, Oct 3, 2026